168 related articles for article (PubMed ID: 18313772)
1. Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.
Carraway RE; Hassan S; Dobner PR
Regul Pept; 2008 Apr; 147(1-3):96-109. PubMed ID: 18313772
[TBL] [Abstract][Full Text] [Related]
2. Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells.
Carraway RE; Gui X; Cochrane DE
J Pharmacol Exp Ther; 2003 Nov; 307(2):640-50. PubMed ID: 14570823
[TBL] [Abstract][Full Text] [Related]
3. Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells.
Carraway RE; Hassan S; Cochrane DE
Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):93-107. PubMed ID: 16406549
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling of bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization by phorbol ester in canine cultured tracheal epithelial cells.
Yang CM; Luo SF; Wu WB; Pan SL; Tsai YJ; Chiu CT; Wang CC
Br J Pharmacol; 1998 Oct; 125(4):627-36. PubMed ID: 9831895
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress.
Carraway RE; Hassan S
Regul Pept; 2007 Jun; 141(1-3):140-53. PubMed ID: 17289170
[TBL] [Abstract][Full Text] [Related]
6. Possible role of duration of PKC-induced ERK activation in the effects of agonists and phorbol esters on DNA synthesis in Panc-1 cells.
Rácz GZ; Szucs A; Szlávik V; Vág J; Burghardt B; Elliott AC; Varga G
J Cell Biochem; 2006 Aug; 98(6):1667-80. PubMed ID: 16637058
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.
Tatsuda Y; Iguchi K; Usui S; Suzui M; Hirano K
Eur J Pharmacol; 2010 Feb; 627(1-3):348-53. PubMed ID: 19903468
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
van der Merwe JQ; Moreau F; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
[TBL] [Abstract][Full Text] [Related]
9. The regulation of glycine transporter GLYT1 is mainly mediated by protein kinase Calpha in C6 glioma cells.
Morioka N; Abdin JM; Morita K; Kitayama T; Nakata Y; Dohi T
Neurochem Int; 2008 Dec; 53(6-8):248-54. PubMed ID: 18778746
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester-mediated neurotensin secretion is dependent on the PKC-alpha and -delta isoforms.
Li J; Hellmich MR; Greeley GH; Townsend CM; Evers BM
Am J Physiol Gastrointest Liver Physiol; 2002 Nov; 283(5):G1197-206. PubMed ID: 12381534
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function.
Mundell SJ; Jones ML; Hardy AR; Barton JF; Beaucourt SM; Conley PB; Poole AW
Mol Pharmacol; 2006 Sep; 70(3):1132-42. PubMed ID: 16804093
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors.
Jackson A; Sedaghat K; Minerds K; James C; Tiberi M
J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
[TBL] [Abstract][Full Text] [Related]
15. Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes.
Luiken JJ; Ouwens DM; Habets DD; van der Zon GC; Coumans WA; Schwenk RW; Bonen A; Glatz JF
J Endocrinol; 2009 May; 201(2):199-209. PubMed ID: 19273501
[TBL] [Abstract][Full Text] [Related]
16. Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both.
Cohen G; Makranz C; Spira M; Kodama T; Reichert F; Rotshenker S
Glia; 2006 Apr; 53(5):538-50. PubMed ID: 16374778
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells.
Rusnak JM; Lazo JS
Exp Cell Res; 1996 Apr; 224(1):189-99. PubMed ID: 8612685
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Ser166 in RGS5 by protein kinase C causes loss of RGS function.
Moroi K; Nishiyama M; Kawabata S; Ichiba H; Yajima T; Kimura S
Life Sci; 2007 Jun; 81(1):40-50. PubMed ID: 17540411
[TBL] [Abstract][Full Text] [Related]
19. Internalization-dependent regulation of HT29 cell proliferation by neurotensin.
Navarro V; Martin S; Mazella J
Peptides; 2006 Oct; 27(10):2502-7. PubMed ID: 16870305
[TBL] [Abstract][Full Text] [Related]
20. Characterization of phorbol esters activity on individual mammalian protein kinase C isoforms, using the yeast phenotypic assay.
Saraiva L; Fresco P; Pinto E; Gonçalves J
Eur J Pharmacol; 2004 May; 491(2-3):101-10. PubMed ID: 15140626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
